# PharmaCyte Biotech, Inc.: Form 8-K, filed Jan 9, 2015

- Company: [PharmaCyte Biotech, Inc.](/companies/pmcb.md) (CIK 1157075)
- Form: 8-K
- Filed: 2015-01-09
- Accepted by EDGAR: Jan 9, 2015, 11:33 ET
- Period: 2015-01-06
- Accession: 0001019687-15-000112
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1157075/000101968715000112/pharm_8k-010614.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157075/000101968715000112/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157075/000101968715000112/pharm_8k-010614.htm

Filed Jan 9, 2015.
Source: SEC EDGAR, the filing index for accession 0001019687-15-000112. Last ingested by Listed: Nov 14, 2026, 20:52 ET. No prices; not investment advice.
